LINE

Text:AAAPrint
Sci-tech

China's phase 2 trial finds COVID-19 vaccine safe, inducing immune response -- The Lancet

1
2020-07-20 23:01:24Xinhua Editor : Wang Fan ECNS App Download
File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)

File photo shows a staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing. (Xinhua File/Zhang Yuwei)

Special: Battle Against Novel Coronavirus

A phase 2 trial of a COVID-19 vaccine candidate in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.

MorePhoto

Most popular in 24h

MoreTop news

MoreVideo

LINE
Media partners: People's Daily Online | Xinhuanet | China.org.cn | ChinaDaily.com.cn | CGTN | Globaltimes.cn | Chinaplus.cri.cn | Shine.cn | JSCHINA | China Military Online | Taiwan.cn | Sina English | Caijing | Caixin Online | CE.cn | GMW.cn | Women of China | newsgd.com
Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2020 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.